title: Effectiveness of HMG-CoA reductase inhibitors is modified by the ACE insertion deletion polymorphism.
authors.forename: Anke-Hilse
authors.initials: AH
authors.lastname: Maitland-van der Zee
authors.forename: Olaf H
authors.initials: OH
authors.lastname: Klungel
authors.forename: Hubertus G M
authors.initials: HG
authors.lastname: Leufkens
authors.forename: Anthonius
authors.initials: A
authors.lastname: de Boer
authors.forename: Bruno H Ch
authors.initials: BH
authors.lastname: Stricker
authors.forename: Albert
authors.initials: A
authors.lastname: Hofman
authors.forename: Jacqueline C M
authors.initials: JC
authors.lastname: Witteman
authors.forename: Cornelia M
authors.initials: CM
authors.lastname: van Duijn
authors.forename: John J P
authors.initials: JJ
authors.lastname: Kastelein
mesh_terms: D000368:Aged; D003327:Coronary Disease / Q000235:genetics / Q000401:mortality* / Q000517:prevention & control*; D005260:Female; D005500:Follow-Up Studies; D005838:Genotype; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D007703:Peptidyl-Dipeptidase A / Q000235:genetics*; D011110:Polymorphism, Genetic / Q000235:genetics*; D016896:Treatment Outcome
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007703:Peptidyl-Dipeptidase A